|
|
|
Volumn 52, Issue 3, 2004, Pages 398-
|
|
Non-equivalence of bioavailability between generic and branded form of sodium valproate [8]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBAMAZEPINE;
EXCIPIENT;
GENERIC DRUG;
PHENYTOIN;
VALPROIC ACID;
ADULT;
BIOEQUIVALENCE;
CAREGIVER;
CASE REPORT;
DISEASE CONTROL;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG INTOXICATION;
HUMAN;
LETTER;
MENTAL DEFICIENCY;
MYOCLONUS SEIZURE;
NURSING HOME;
PATIENT CARE;
TONIC CLONIC SEIZURE;
ADULT;
ANTICONVULSANTS;
BIOLOGICAL AVAILABILITY;
DRUGS, GENERIC;
EPILEPSY, GENERALIZED;
HUMANS;
MENTAL RETARDATION;
THERAPEUTIC EQUIVALENCY;
VALPROIC ACID;
|
|
EID: 7244238084
PISSN: 00283886
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (9)
|
|
References (4)
|
